INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI) Stock Price, Quote, News & History

INTIOTCQB

Trade with Public

$0.1000

0.013415.47%

At close: Sep 11, 5:00 PM EST

OverviewNews Financials Sentiment Ownership Compare

Key Statistics

Open

$0.06

$0.10

Volume / Avg.

800.00 / 17.68K

Day Range

$0.06 - $0.10

52 Wk Range

0.04 - 0.12

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Inhibitor Therapeutics Inc News

PRO
indie Semiconductor To Acquire TeraXion; Terms Not Disclosed

Innovative Laser Portfolio Complements indie's LiDAR Solutions for ADAS/Autonomous Vehicles Highly Integrated Architectures Promise 10x Improvements in System Performance and Cost Expands Geographic Design and

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.22M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

Free Cash Flow (TTM)

-3.22M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-3.22M

Valuation Metrics

Enterprise Value

$17.01M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

-23.09%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.01

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$515.76K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.06

$0.10

Volume / Avg.

800.00 / 17.68K

Day Range

$0.06 - $0.10

52 Wk Range

0.04 - 0.12

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and potentially commercializing therapeutics based on already approved active pharmaceutical ingredients, with a primary focus on basal cell carcinoma nevus synd...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

INTI

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

INTI

FAQ

How do I buy INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI) stock?

You can purchase shares of INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (OTCQB:INTI) through any online brokerage.

View our list of the best stock brokerages

Who are INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI) competitors?

There are no as such competitors for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc..

What is the forecast, or price target, for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI) stock?

There is no analysis for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. to provide a consensus price target.

What is the current price for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI)?

The stock price for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (OTCQB: INTI) is $0.1 last updated September 11, 2026 at 2:09 PM EDT.

Does INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI) pay a dividend?

There are no upcoming dividends for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc..

When is INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (OTCQB:INTI) reporting earnings?

INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. does not have any upcoming earnings scheduled.

Is INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI) going to split?

There is no upcoming split for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc..

What sector and industry does INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI) operate in?

INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.